Policlinico di Monserrato
Monserrato, CA, 09042, Italy
NCT Number: NCT04273711
Obesity is a growing public health concern in most western countries. More and more patients with high body mass index (BMI) are undergoing surgical procedures of all kinds and, in this context, obese patients are undergoing thyroid surgery more than ever before. This study showed that obesity, in the field of thyroid surgery, is not associated with any increase of postoperative complications. Thus, it is possible to conclude that thyroidectomy can be performed safely in obese patients.
Looking for future studies?
Notify MeAll sexes
Observational
Monserrato, CA, 09042, Italy
Background: Obesity is a growing public health concern in most western countries. More and more patients with high body mass index (BMI) are undergoing surgical procedures of all kinds and, in this context, obese patients are undergoing thyroid surgery more than ever before. The aim of the present study was to evaluate whether thyroidectomy can be considered safe in obese patients.
Methods: Patients undergoing thyroidectomy in our Unit between January 2014 and December 2018 were retrospectively analysed. Patients were divided into 2 groups: those with BMI < 30 kg/m2 were included in Group A, while those with BMI ≥ 30 kg/m2 in Group B.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
-
Time frame: 1 year
Occurrence of postoperative complications
Time frame: 1 day
Evaluation of operatives times
Time frame: up to 2 weeks
Evaluation of postoperative stay
University of Cagliari
Other
Can Thyroidectomy be Considered Safe in Obese Patients? Retrospective Cohort Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03048708
Autoimmune Diseases, Autoimmune Thyroiditis
View Trial DetailsNCT04752202
Autoimmune Diseases, Body Weight
Bialystok, Poland
View Trial DetailsNCT02950142
Acute Coronary Syndrome, Anemia
Leuven, Belgium
View Trial DetailsNCT00521729
Body Weight, Endocrine System Diseases
Bethesda, Maryland, United States
View Trial Details